A share price of Profound Medical Corp [PROF] is currently trading at $4.75, up 11.76%. An important factor to consider is whether the stock is rising or falling in short-term value. The PROF shares have lost -15.63% over the last week, with a monthly amount drifted -15.78%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Profound Medical Corp [NASDAQ: PROF] stock has seen the most recent analyst activity on July 23, 2024, when Lake Street initiated its Buy rating and assigned the stock a price target of $16.50. Previously, Stifel upgraded its rating to Buy on July 16, 2024, and elevated its price target to $12. On November 28, 2023, Stifel initiated with a Hold rating and assigned a price target of $11 on the stock. Raymond James downgraded its rating to a Outperform and increased its price target to $200 on August 04, 2023. Jefferies downgraded its rating to a Hold and raised its price target to $10 on March 21, 2023.
Profound Medical Corp experienced fluctuations in its stock price throughout the past year between $3.89 and $9.87. Currently, Wall Street analysts expect the stock to reach $15.17 within the next 12 months. Profound Medical Corp [NASDAQ: PROF] shares were valued at $4.75 at the most recent close of the market. An investor can expect a potential return of 219.37% based on the average PROF price forecast.
Analyzing the PROF fundamentals
Trailing Twelve Months sales for Profound Medical Corp [NASDAQ:PROF] were 11.84M which represents -0.99% decline. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -1.85%, Pretax Profit Margin comes in at -2.84%, and Net Profit Margin reading is -2.84%. To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -0.71 and Total Capital is -0.38. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.40 points at the first support level, and at 4.04 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.97, and for the 2nd resistance point, it is at 5.18.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Profound Medical Corp [NASDAQ:PROF] is 8.53. On the other hand, the Quick Ratio is 7.07, and the Cash Ratio is 8.77. Considering the valuation of this stock, the price to sales ratio is 12.06, the price to book ratio is 3.64.
Transactions by insiders
Recent insider trading involved Menawat Arun Swarup, CEO, that happened on May 16 ’25 when 12027.0 shares were purchased. CEO, Menawat Arun Swarup completed a deal on May 15 ’25 to buy 10003.0 shares. Meanwhile, Officer Goodman Abbey bought 13014.0 shares on Nov 12 ’24.
